“The European Commission’s Pharmaceutical Strategy: Implications for Intellectual Property Rights and Innovation in the Industry”

2023-04-23 07:32:37

This has to be the industry’s biggest overhaul for 20 years, and its announcement has already been delayed multiple times, tell it Financial Times. On Wednesday, the European Commission must present the axes of its new pharmaceutical strategy, expected since the pandemic; pharmaceutical companies fear that intellectual property rights will be reduced from 10 to 8 years and Germany followed by other smaller countries wrote a position paper warning that it would harm innovation if exclusivity periods were reduced, with generics that would arrive on the market more quickly.

1682235923
#Germany #concerned #pharmaceutical #strategy

Photo of author

Alexandra Hartman Editor-in-Chief

Editor-in-Chief Prize-winning journalist with over 20 years of international news experience. Alexandra leads the editorial team, ensuring every story meets the highest standards of accuracy and journalistic integrity.

“OL vs OM: Everything You Need to Know – TV Schedule, Probable Lineups and Match Preview”

“My Climate Future: Understanding the Impacts of Global Warming and Climate Change”

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.